Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Lacosamide 100 mg
DRUG
3 trials
Sponsors
UCB Pharma SA
, University of California, San Francisco
, Xiangya Hospital of Central South University
Conditions
Alcohol Use Disorder
Alzheimer Disease 3
Epilepsy
Partial Onset Seizures
Phase 2
Pilot Human Lab Study of Lacosamide in Alcohol Use Disorder (AUD)
Completed
NCT03897348
University of California, San Francisco
Alcohol Use Disorder
Start: 2018-09-17
End: 2019-06-12
Updated: 2022-06-28
Phase 3
A Trial to Evaluate the Efficacy and Safety of Adjunctive Therapy With Lacosamide in Adults With Partial-Onset Seizures
Completed
NCT01710657
UCB Pharma SA
Epilepsy, Partial Onset Seizures
Start: 2012-09-30
End: 2014-08-31
Updated: 2017-08-25
Phase 4
Improvement Effect of Lacosamide and Levetiracetam on Cognitive in Alzheimer's Disease Patients With Epilepsy
NCT05969054
Xiangya Hospital of Central South University
Alzheimer Disease 3, Epilepsy
Start: 2023-07-05
End: 2025-12-31
Target: 140
Updated: 2023-08-04
Related Papers
Safety and efficacy of adjunctive lacosamide in Chinese and Japanese adults with epilepsy and focal seizures: A long-term, open-label extension of a randomized, controlled trial
Epilepsy Research
2021-06-29
24 citations
Efficacy and safety of adjunctive lacosamide for the treatment of partial-onset seizures in Chinese and Japanese adults: A randomized, double-blind, placebo-controlled study.
2016-09-01
35 citations